Walleye Capital
FLXN

Walleye Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Walleye Capital’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,100
Closed -$64K – 1960
2019
Q4 		$64K Buy
+3,100
New +$52.3K ﹤0.01% 1469

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Walleye Capital's FLXN Position: Q1 2020 in Review

Walleye Capital sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 22,734 shares — an estimated $470K sold.

Walleye Capital first reported a position in FLXN in Q4 2019 and held it in 1 quarter. The position peaked at $470K in Q4 2019. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

  • Walleye Capital reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Walleye Capital sold 22,734 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $470K.
  • Walleye Capital first reported a position in Flexion Therapeutics, Inc. in Q4 2019 and held it in 1 quarter.
  • Walleye Capital's Flexion Therapeutics, Inc. position peaked at $470K in Q4 2019.
  • 123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.